12 matches for your search in the start-up spotlight
rss
DIOSynVax customises vaccine antigen design to maximise the protection that vaccines can provide worldwide against existing and future viruses. Grounded firmly in virus structure and evolution, our method is patent protected, combining computational biology with in vitro and in vivo validation, ...
METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas. The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism-driven quantum mechanics and molecular ...
Cellino is on a mission to make personalized, autologous cell therapies accessible for patients. Stem cell-derived regenerative medicines are poised to cure some of the toughest diseases within this decade, including Parkinson’s, diabetes, and heart disease. Patient-specific cells provide the ...
Echion Technologies supplies high-power Li-ion battery anode materials that enable superfast charging and low Total Cost of Ownership for the most demanding applications.
Biobot Analytics develops cutting-edge technology to transform sewers into public health observatories. Wastewater contains valuable information about the health of communities. We collect it. We analyze it. We tell you how to leverage it to make your city better. Our first product is to measure ...
The Kebotix self-driving lab combines data and AI with robotics to discover and create advanced chemicals and materials at a faster rate and at the push of a button. Kebotix offers inventive solutions that create new, disruptive chemistries and materials at a rapid pace while reducing costs. Our ...
Our scientists help industry-leading companies understand — and capitalize on — the capabilities of quantum computing today, and the possibilities of quantum computing tomorrow. With Fortune Global 1000 companies, we are developing solutions for a wide range of industries including chemistry, ...
ReviveMed is an MIT spinout, artificial intelligence (AI)-driven drug discovery platform by uniquely leverages data from small molecules or metabolites in the human body. Located in the heart of biotech innovation in Cambridge, ReviveMed uniquely overcomes the difficulties of identifying a large ...
Celsius Therapeutics is a community of scientists, technologists, clinicians and drug hunters leveraging single-cell genomic analysis to develop life-changing medicines. Our common goal is to markedly improve human health by integrating data, experience and insight. Our environment is rigorous, ...
Intellegens is a spin-out from the University of Cambridge that has developed a unique Artificial Intelligence (AI) method for training neural networks from incomplete data sets. The technique, developed in the Department of Physics, is being applied to drug discovery and material design problems.
